Vedana Therapeutics, Inc.
1 known investors
Vedana Therapeutics develops next-generation biologic medicines for migraine prevention, targeting PACAP and CGRP-independent pathways to address unmet needs in patients inadequately controlled by current therapies. The company focuses on the neurological and pharmaceutical sectors to serve the global migraine patient population.
Investors · 1
Frequently asked questions
- What does Vedana Therapeutics, Inc. do?
- Vedana Therapeutics develops next-generation biologic medicines for migraine prevention, targeting PACAP and CGRP-independent pathways to address unmet needs in patients inadequately controlled by current therapies. The company focuses on the neurological and pharmaceutical sectors to serve the global migraine patient population.
- Who are Vedana Therapeutics, Inc.'s investors?
- Vedana Therapeutics, Inc.'s investors include Canaan Partners.